Rhenman & Partners Asset Management AB as of March 31, 2025
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 94 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| UnitedHealth (UNH) | 4.7 | $41M | 77k | 523.75 | |
| Eli Lilly & Co. (LLY) | 4.0 | $35M | 42k | 825.91 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.7 | $32M | 67k | 484.82 | |
| McKesson Corporation (MCK) | 3.7 | $32M | 47k | 672.99 | |
| Boston Scientific Corporation (BSX) | 3.5 | $30M | 300k | 100.88 | |
| Glaukos (GKOS) | 3.1 | $27M | 270k | 98.42 | |
| Gilead Sciences (GILD) | 3.0 | $26M | 234k | 112.05 | |
| Procept Biorobotics Corp (PRCT) | 3.0 | $26M | 448k | 58.26 | |
| Intuitive Surgical Com New (ISRG) | 2.9 | $26M | 52k | 495.27 | |
| Alignment Healthcare (ALHC) | 2.9 | $25M | 1.3M | 18.62 | |
| Medtronic SHS (MDT) | 2.6 | $23M | 255k | 89.86 | |
| Molina Healthcare (MOH) | 2.6 | $23M | 68k | 329.39 | |
| Anthem (ELV) | 2.4 | $21M | 49k | 434.96 | |
| Regeneron Pharmaceuticals (REGN) | 2.3 | $20M | 32k | 634.23 | |
| Cooper Cos (COO) | 2.3 | $20M | 236k | 84.35 | |
| Bristol Myers Squibb (BMY) | 2.3 | $20M | 325k | 60.99 | |
| Natera (NTRA) | 2.3 | $20M | 139k | 141.41 | |
| EXACT Sciences Corporation (EXAS) | 2.2 | $19M | 440k | 43.29 | |
| BioMarin Pharmaceutical (BMRN) | 2.2 | $19M | 265k | 70.69 | |
| Abbvie (ABBV) | 2.1 | $19M | 89k | 209.52 | |
| Tenet Healthcare Corp Com New (THC) | 2.0 | $17M | 127k | 134.50 | |
| Insulet Corporation (PODD) | 1.8 | $16M | 61k | 262.61 | |
| CVS Caremark Corporation (CVS) | 1.8 | $16M | 236k | 67.75 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.8 | $15M | 124k | 124.15 | |
| Insmed Com Par $.01 (INSM) | 1.6 | $14M | 186k | 76.29 | |
| Oscar Health Cl A (OSCR) | 1.5 | $13M | 1.0M | 13.11 | |
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $13M | 48k | 270.02 | |
| Royalty Pharma Shs Class A (RPRX) | 1.5 | $13M | 411k | 31.13 | |
| Axsome Therapeutics (AXSM) | 1.5 | $13M | 110k | 116.63 | |
| Humana (HUM) | 1.4 | $12M | 47k | 264.60 | |
| Dex (DXCM) | 1.2 | $11M | 155k | 68.29 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $9.9M | 90k | 110.60 | |
| Zimmer Holdings (ZBH) | 1.1 | $9.9M | 87k | 113.18 | |
| Cigna Corp (CI) | 1.1 | $9.3M | 28k | 329.00 | |
| AmerisourceBergen (COR) | 1.0 | $9.0M | 32k | 278.09 | |
| Danaher Corporation (DHR) | 1.0 | $8.6M | 42k | 205.00 | |
| Centene Corporation (CNC) | 0.9 | $7.6M | 126k | 60.71 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.8 | $7.3M | 565k | 12.97 | |
| Tg Therapeutics (TGTX) | 0.8 | $7.0M | 178k | 39.43 | |
| Abbott Laboratories (ABT) | 0.8 | $6.9M | 52k | 132.65 | |
| Biogen Idec (BIIB) | 0.8 | $6.8M | 50k | 136.84 | |
| Align Technology (ALGN) | 0.8 | $6.6M | 42k | 158.86 | |
| Thermo Fisher Scientific (TMO) | 0.7 | $6.3M | 13k | 497.60 | |
| Hca Holdings (HCA) | 0.7 | $5.8M | 17k | 345.55 | |
| Syndax Pharmaceuticals (SNDX) | 0.6 | $5.3M | 433k | 12.29 | |
| Anteris Technologies Global (AVR) | 0.5 | $4.7M | 1.3M | 3.64 | |
| Astrana Health Com New (ASTH) | 0.5 | $4.7M | 150k | 31.01 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.5 | $4.4M | 70k | 63.49 | |
| Becton, Dickinson and (BDX) | 0.5 | $4.4M | 19k | 229.06 | |
| Cytokinetics Com New (CYTK) | 0.5 | $4.2M | 104k | 40.19 | |
| Iqvia Holdings (IQV) | 0.4 | $3.9M | 22k | 176.30 | |
| Janux Therapeutics (JANX) | 0.4 | $3.8M | 142k | 27.00 | |
| Encompass Health Corp (EHC) | 0.4 | $3.8M | 37k | 101.28 | |
| Akero Therapeutics (AKRO) | 0.4 | $3.7M | 93k | 40.48 | |
| Nuvalent Inc-a (NUVL) | 0.4 | $3.7M | 53k | 70.92 | |
| Mirum Pharmaceuticals (MIRM) | 0.4 | $3.3M | 74k | 45.05 | |
| Biontech Se Sponsored Ads (BNTX) | 0.4 | $3.3M | 36k | 91.06 | |
| Krystal Biotech (KRYS) | 0.4 | $3.2M | 18k | 180.30 | |
| Merus N V (MRUS) | 0.4 | $3.1M | 75k | 42.09 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $3.0M | 82k | 36.21 | |
| Nurix Therapeutics (NRIX) | 0.3 | $3.0M | 249k | 11.88 | |
| Merck & Co (MRK) | 0.3 | $3.0M | 33k | 89.76 | |
| Arcellx Common Stock (ACLX) | 0.3 | $2.9M | 44k | 65.60 | |
| Inspire Med Sys (INSP) | 0.3 | $2.5M | 16k | 159.28 | |
| Ionis Pharmaceuticals (IONS) | 0.3 | $2.4M | 81k | 30.17 | |
| Viking Therapeutics (VKTX) | 0.3 | $2.4M | 100k | 24.15 | |
| Dianthus Therapeutics (DNTH) | 0.3 | $2.3M | 127k | 18.14 | |
| Privia Health Group (PRVA) | 0.3 | $2.2M | 98k | 22.45 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $2.2M | 648k | 3.33 | |
| Xencor (XNCR) | 0.2 | $2.1M | 196k | 10.64 | |
| Bruker Corporation (BRKR) | 0.2 | $1.8M | 42k | 41.74 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.2 | $1.8M | 45k | 39.07 | |
| Esperion Therapeutics (ESPR) | 0.2 | $1.5M | 1.1M | 1.44 | |
| Inmune Bio Ord (INMB) | 0.2 | $1.4M | 178k | 7.81 | |
| Denali Therapeutics (DNLI) | 0.2 | $1.4M | 100k | 13.60 | |
| Vir Biotechnology (VIR) | 0.1 | $1.3M | 200k | 6.48 | |
| Alkermes SHS (ALKS) | 0.1 | $1.3M | 39k | 33.02 | |
| Kura Oncology (KURA) | 0.1 | $1.3M | 195k | 6.60 | |
| Arvinas Ord (ARVN) | 0.1 | $1.3M | 183k | 7.02 | |
| Amgen (AMGN) | 0.1 | $1.2M | 4.0k | 311.55 | |
| Geron Corporation (GERN) | 0.1 | $1.2M | 783k | 1.59 | |
| Icon SHS (ICLR) | 0.1 | $1.2M | 7.0k | 174.99 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $1.2M | 70k | 17.31 | |
| Relay Therapeutics (RLAY) | 0.1 | $1.2M | 460k | 2.62 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.2M | 35k | 33.55 | |
| Medpace Hldgs (MEDP) | 0.1 | $1.2M | 3.8k | 304.69 | |
| Annexon (ANNX) | 0.1 | $888k | 460k | 1.93 | |
| Immunocore Hldgs Ads (IMCR) | 0.1 | $839k | 28k | 29.67 | |
| Avantor (AVTR) | 0.1 | $775k | 48k | 16.21 | |
| Ideaya Biosciences (IDYA) | 0.1 | $647k | 40k | 16.38 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $618k | 28k | 21.87 | |
| Penumbra (PEN) | 0.1 | $588k | 2.2k | 267.41 | |
| Repligen Corporation (RGEN) | 0.1 | $573k | 4.5k | 127.24 | |
| Immunovant (IMVT) | 0.1 | $443k | 26k | 17.09 |
